Promotion of antimicrobial stewardship following issuance of the antimicrobial resistance national action plan in Japan: A systematic review of 2016–2020
H Honda, T Goto, Y Uehara, A Takamatsu - International Journal of …, 2023 - Elsevier
Background Antimicrobial resistance (AMR) represents a global threat with the potential to
cause a significant healthcare burden. In 2016, the Japanese Government issued the …
cause a significant healthcare burden. In 2016, the Japanese Government issued the …
Exploration of trends in antimicrobial use and their determinants based on dispensing information collected from pharmacies throughout Japan: a first report
Y Muraki, M Maeda, R Inose, K Yoshimura, N Onizuka… - Antibiotics, 2022 - mdpi.com
The purpose of this study was to evaluate the defined daily doses (DDD)/1000
prescriptions/month (DPM) as a new indicator that can be used in pharmacies, and to …
prescriptions/month (DPM) as a new indicator that can be used in pharmacies, and to …
Accuracy and Consequences of using Trial-of-antibiotics for TB diagnosis (ACT-TB Study)
TH Divala - 2021 - researchonline.lshtm.ac.uk
Background: With 1.4 million deaths in 2019, tuberculosis remains a leading global
infectious cause of death, second only to COVID-19 in 2020. Antimicrobial resistant …
infectious cause of death, second only to COVID-19 in 2020. Antimicrobial resistant …
[PDF][PDF] 薬剤耐性(AMR) 対策アクションプラン2023―2027 の概要
具芳明 - 日本臨床微生物学会雑誌= The journal of the Japanese …, 2024 - jscm.org
薬剤耐性 (AMR) 対策アクションプラン 2023―2027 (アクションプラン 2023) は, 2016
年に開始されたアクションプラン (アクションプラン 2016) の改定版として 2023 年 4 …
年に開始されたアクションプラン (アクションプラン 2016) の改定版として 2023 年 4 …